managing mdros in ltcfs national center for emerging and zoonotic infectious diseases division of...
TRANSCRIPT
![Page 1: Managing MDROs in LTCFs National Center for Emerging and Zoonotic Infectious Diseases Division of Healthcare Quality Promotion Nimalie D. Stone, MD/MS](https://reader036.vdocuments.us/reader036/viewer/2022081518/551bcb84550346b4588b5143/html5/thumbnails/1.jpg)
Managing MDROs in LTCFs
National Center for Emerging and Zoonotic Infectious Diseases
Division of Healthcare Quality Promotion
Nimalie D. Stone, MD/MSMedical Epidemiologist for LTC
GA LTC IC courseWinter/Spring 2011
![Page 2: Managing MDROs in LTCFs National Center for Emerging and Zoonotic Infectious Diseases Division of Healthcare Quality Promotion Nimalie D. Stone, MD/MS](https://reader036.vdocuments.us/reader036/viewer/2022081518/551bcb84550346b4588b5143/html5/thumbnails/2.jpg)
Objectives
q Review basics about common bacteria which can develop antibiotic resistance in the healthcare setting
q Discuss mechanisms by which antibiotic resistance emerges and spreads
q Identify strategies for preventing MDRO transmission
![Page 3: Managing MDROs in LTCFs National Center for Emerging and Zoonotic Infectious Diseases Division of Healthcare Quality Promotion Nimalie D. Stone, MD/MS](https://reader036.vdocuments.us/reader036/viewer/2022081518/551bcb84550346b4588b5143/html5/thumbnails/3.jpg)
Basics on Bacteria
• Bacteria have different characteristics that allow us to identify them in the lab• Growth patterns, structure of the cell
• We use these characteristics to develop antibiotics
Gram Stain Positive(purple)
Gram Stain Negative(pink/red)
![Page 4: Managing MDROs in LTCFs National Center for Emerging and Zoonotic Infectious Diseases Division of Healthcare Quality Promotion Nimalie D. Stone, MD/MS](https://reader036.vdocuments.us/reader036/viewer/2022081518/551bcb84550346b4588b5143/html5/thumbnails/4.jpg)
Common types of Bacteria
Gram positive q Most are cocci, “round bacteria”
q Streptococcus, Staphylococcus, Enterococcus
q Clostridium difficile (C. diff) is a Gram positive rod
Gram negative q Most are baccili, “rod-shaped
bacteria”q Enterobacteriaceae: E coli,
Klebsiella, Enterobacter , Proteusq Pseudomonas
![Page 5: Managing MDROs in LTCFs National Center for Emerging and Zoonotic Infectious Diseases Division of Healthcare Quality Promotion Nimalie D. Stone, MD/MS](https://reader036.vdocuments.us/reader036/viewer/2022081518/551bcb84550346b4588b5143/html5/thumbnails/5.jpg)
Normal Bacterial Carriage• People have bacteria
living in and on us all the time
• Some live on our skin, some in our nose and throats, others in our bowels
• Our bodies need these bacteria to help us
• Some digest food/nutrients, others block bad bugs
• These “colonizing” bacteria aren’t harmful• Only bacteria that invade our system and
cause illness need to be treated
![Page 6: Managing MDROs in LTCFs National Center for Emerging and Zoonotic Infectious Diseases Division of Healthcare Quality Promotion Nimalie D. Stone, MD/MS](https://reader036.vdocuments.us/reader036/viewer/2022081518/551bcb84550346b4588b5143/html5/thumbnails/6.jpg)
Antibiotics 101
q Antibiotics are drugs that treat and kill bacteriaq They are grouped into classes based on their
structure and activity§ Narrow-spectrum target a few specific bacteria § Broad-spectrum can kill a wide variety of bacteria
q Infection prevention programs track certain “bug-drug” combinations for evidence that the bacteria is getting resistant§ Bacteria with resistance can cause patients to have
more severe, costly infections which are harder to treat
![Page 7: Managing MDROs in LTCFs National Center for Emerging and Zoonotic Infectious Diseases Division of Healthcare Quality Promotion Nimalie D. Stone, MD/MS](https://reader036.vdocuments.us/reader036/viewer/2022081518/551bcb84550346b4588b5143/html5/thumbnails/7.jpg)
Antibiotic Classes
Penicillinsq Examples: Penicillin, amoxicillin, ampicillin, methicillinq Penicillins can be combined with a drug to help them
overcome certain bacterial resistance§ Amoxicillin + Clavulante = Augmentin; § Piperacillin + tazobactam = Zosyn
Cephalosporins (cousins to penicillins)q 1st generation (more gram positive activity):
Cephalexin, Cefazolinq 3rd/4th generation (more gram negative): Ceftriaxone,
Ceftazidime
![Page 8: Managing MDROs in LTCFs National Center for Emerging and Zoonotic Infectious Diseases Division of Healthcare Quality Promotion Nimalie D. Stone, MD/MS](https://reader036.vdocuments.us/reader036/viewer/2022081518/551bcb84550346b4588b5143/html5/thumbnails/8.jpg)
Antibiotic Classes (cont)Carbapenemsq Examples: Imipenem, meropenem, ertapenemq Extremely broad-spectrum, among the most powerful
antibiotics we currently
Miscellaneous drugs with only gram positive activity: Vancomycin, linezolid, daptomycin
q Vancomycin is the primary treatment for Methicillin-resistant Staphylococcus aureus (MRSA)§ Oral vancomycin is ONLY used to treat C difficile;§ IV Vancomycin must be used to treat all other infections
q Enterococci that develop resistance to Vancomycin are called Vancomycin-resistant enterococci (VRE)
![Page 9: Managing MDROs in LTCFs National Center for Emerging and Zoonotic Infectious Diseases Division of Healthcare Quality Promotion Nimalie D. Stone, MD/MS](https://reader036.vdocuments.us/reader036/viewer/2022081518/551bcb84550346b4588b5143/html5/thumbnails/9.jpg)
Antibiotic Classes (cont)Fluoroquinolonesq 1st generation (Ciprofloxacin) mostly gram neg
activity, often used for UTI treatmentq 2nd/3rd gen (Levofloxacin/Moxifloxacin) have broader
activity, can cover Streptococcus pneumoniae and other respiratory/sinus bacteria
Aminoglycosidesq Examples: Gentamicin, Tobramycin, Amikacinq Excellent gram negative drugs – especially for urinary tractq Aren’t used as much because can be toxic to the kidneys,
need to be monitored when used
![Page 10: Managing MDROs in LTCFs National Center for Emerging and Zoonotic Infectious Diseases Division of Healthcare Quality Promotion Nimalie D. Stone, MD/MS](https://reader036.vdocuments.us/reader036/viewer/2022081518/551bcb84550346b4588b5143/html5/thumbnails/10.jpg)
Antibiotic Classes (cont)
Miscellaneous drugsq Trimethoprim/Sulfamethoxazole (Bactrim):
Considered by many to be narrow spectrum, but has Gram neg and Gram pos activity, used to treat UTIs, also good for MRSA skin infections
q Azithromycin (“Z-pack”): Also considered more narrow spectrum, good for respiratory/sinus infections
q Metronidazole (Flagyl): One of the main treatments for C. difficile infections
![Page 11: Managing MDROs in LTCFs National Center for Emerging and Zoonotic Infectious Diseases Division of Healthcare Quality Promotion Nimalie D. Stone, MD/MS](https://reader036.vdocuments.us/reader036/viewer/2022081518/551bcb84550346b4588b5143/html5/thumbnails/11.jpg)
Mechanisms of antibiotic resistanceq Production of proteins that
destroy antibioticsq Beta-lactamasesq Carbapenemases
q Change their cell structure so antibiotics can’t bind and block their function
q Reduce their antibiotic exposureq Pump drugs outq Increase cell barriers to
keep drug outhttp://bioinfo.bact.wisc.edu/themicrobialworld/bactresanti.html
![Page 12: Managing MDROs in LTCFs National Center for Emerging and Zoonotic Infectious Diseases Division of Healthcare Quality Promotion Nimalie D. Stone, MD/MS](https://reader036.vdocuments.us/reader036/viewer/2022081518/551bcb84550346b4588b5143/html5/thumbnails/12.jpg)
![Page 13: Managing MDROs in LTCFs National Center for Emerging and Zoonotic Infectious Diseases Division of Healthcare Quality Promotion Nimalie D. Stone, MD/MS](https://reader036.vdocuments.us/reader036/viewer/2022081518/551bcb84550346b4588b5143/html5/thumbnails/13.jpg)
Snapshot of resistance patterns: Facility antibiograms
q A yearly summary of the common bacteria from facility cultures and their susceptibility patterns to antibiotics
q Allows you to see trends in resistance over timeq Ask your microbiology lab about it
![Page 14: Managing MDROs in LTCFs National Center for Emerging and Zoonotic Infectious Diseases Division of Healthcare Quality Promotion Nimalie D. Stone, MD/MS](https://reader036.vdocuments.us/reader036/viewer/2022081518/551bcb84550346b4588b5143/html5/thumbnails/14.jpg)
Defining Multidrug-resistance
q Resistant to treatment by several antibiotics from unrelated classes
q Sometimes just one key drug resistance will define an important MDRO, for example, Methicillin-resistance in Staph aureus
q Sometimes bacteria acquire resistance to several classes, often seen in gram negative rodsq Cephalosporin-resistance is a big concern in bacteria
like E coli/Klebsiella which often cause UTIsq Pseudomonas will be resistant to fluoroquinolones,
penicillins, cephalosporins, and carbapenems
![Page 15: Managing MDROs in LTCFs National Center for Emerging and Zoonotic Infectious Diseases Division of Healthcare Quality Promotion Nimalie D. Stone, MD/MS](https://reader036.vdocuments.us/reader036/viewer/2022081518/551bcb84550346b4588b5143/html5/thumbnails/15.jpg)
ABC’s of MDROs
Bacteria Abbrev.
Antibiotic Resistance
Staphylococcus aureus
MRSA Methicillin-resistant
Enterococcus (faecalis/faecium)
VRE Vancomycin-resistant
Enterobacteriaceae(E coli/Klebsiella, etc)
CRE (KPC)
Carbapenem-resistant
Pseudomonas/ Acinetobacter
MDR Many drug classes
![Page 16: Managing MDROs in LTCFs National Center for Emerging and Zoonotic Infectious Diseases Division of Healthcare Quality Promotion Nimalie D. Stone, MD/MS](https://reader036.vdocuments.us/reader036/viewer/2022081518/551bcb84550346b4588b5143/html5/thumbnails/16.jpg)
Staphylococcus aureus
• Derived from the Greek word Staphyle: “Bunch of grapes” and aureus: “gold”
• Part of the normal colonizing bacteria on our skin and in the nose
• Though it colonizes many people, it may not cause infection unless the skin gets broken or the immune system gets weak
![Page 17: Managing MDROs in LTCFs National Center for Emerging and Zoonotic Infectious Diseases Division of Healthcare Quality Promotion Nimalie D. Stone, MD/MS](https://reader036.vdocuments.us/reader036/viewer/2022081518/551bcb84550346b4588b5143/html5/thumbnails/17.jpg)
Methicillin-resistant Staphylococcus aureus (MRSA): An ongoing
problem• First emerged in the US healthcare setting in 1968– Outbreaks linked to transmission via healthcare
workers– Prevalence in nursing homes, 20-50%
• Community-acquired strains are adding to the burden of infection in the healthcare setting
• Increasing public and legislative pressure to address the transmission of MRSA in healthcare
![Page 18: Managing MDROs in LTCFs National Center for Emerging and Zoonotic Infectious Diseases Division of Healthcare Quality Promotion Nimalie D. Stone, MD/MS](https://reader036.vdocuments.us/reader036/viewer/2022081518/551bcb84550346b4588b5143/html5/thumbnails/18.jpg)
Risk Factors for Healthcare- associated MRSA infections
• Previous hospitalization• Increased length of stay prior to onset of
infection• Surgery• Enteral feeding• Prior antibiotics• Invasive devices• History of MRSA colonization• Residence in a long-term care facility
1. Graffunder EM & Venezia RA. J Antimic Chemo 2002;49:999-1005 2. Oztoprak, N. et al. Am J Infec Cont. 2006; 34: 1-5 3. Wertheim et al. Lancet 2005; 5: 751-62 4. Bader, M. Inf Cont Hosp Epi. 2006; 27: 1219-1225
![Page 19: Managing MDROs in LTCFs National Center for Emerging and Zoonotic Infectious Diseases Division of Healthcare Quality Promotion Nimalie D. Stone, MD/MS](https://reader036.vdocuments.us/reader036/viewer/2022081518/551bcb84550346b4588b5143/html5/thumbnails/19.jpg)
Clostridium difficile
• Gram positive rod which grows best without oxygen (anaerobic)
• C. diff has a special growth characteristic called “spores” • Hard outer shells in which
sleeping bacteria can survive in the environment for long periods
• Spores are shed in large numbers during the diarrhea caused by C diff infection (CDI)
![Page 20: Managing MDROs in LTCFs National Center for Emerging and Zoonotic Infectious Diseases Division of Healthcare Quality Promotion Nimalie D. Stone, MD/MS](https://reader036.vdocuments.us/reader036/viewer/2022081518/551bcb84550346b4588b5143/html5/thumbnails/20.jpg)
Steps to C. diff Infection (CDI)
Acquisition of C. difficile
Antibiotic therapy
Changes normal colonic bacteria
C diff over grows and produces toxin
![Page 21: Managing MDROs in LTCFs National Center for Emerging and Zoonotic Infectious Diseases Division of Healthcare Quality Promotion Nimalie D. Stone, MD/MS](https://reader036.vdocuments.us/reader036/viewer/2022081518/551bcb84550346b4588b5143/html5/thumbnails/21.jpg)
n More than half of healthcare associated CDI cases occur in long-term care facilities
n A significant number of individuals admitted to LTC are colonized with C difficilen Up to 20% acquire it while in nursing
homesn CDI is the most commonly identified cause
of acute diarrheal illness in the LTC population
![Page 22: Managing MDROs in LTCFs National Center for Emerging and Zoonotic Infectious Diseases Division of Healthcare Quality Promotion Nimalie D. Stone, MD/MS](https://reader036.vdocuments.us/reader036/viewer/2022081518/551bcb84550346b4588b5143/html5/thumbnails/22.jpg)
CDI risk factors causing disease
Poutanen & Simor. CMAJ. 2004 171:51-8
![Page 23: Managing MDROs in LTCFs National Center for Emerging and Zoonotic Infectious Diseases Division of Healthcare Quality Promotion Nimalie D. Stone, MD/MS](https://reader036.vdocuments.us/reader036/viewer/2022081518/551bcb84550346b4588b5143/html5/thumbnails/23.jpg)
Exposures and risk factors related to CDI in older adults
Simor. JAGS. 2010, e publ
![Page 24: Managing MDROs in LTCFs National Center for Emerging and Zoonotic Infectious Diseases Division of Healthcare Quality Promotion Nimalie D. Stone, MD/MS](https://reader036.vdocuments.us/reader036/viewer/2022081518/551bcb84550346b4588b5143/html5/thumbnails/24.jpg)
C diff. prevention challenges
• Spores are not killed by alcohol hand rubs; the act rubbing your hands with soap under water removes the spores
• Spores are resistant to common cleaners and require bleach to be effectively killed
![Page 25: Managing MDROs in LTCFs National Center for Emerging and Zoonotic Infectious Diseases Division of Healthcare Quality Promotion Nimalie D. Stone, MD/MS](https://reader036.vdocuments.us/reader036/viewer/2022081518/551bcb84550346b4588b5143/html5/thumbnails/25.jpg)
Managing a resident with C diff.• The goal of therapy for C diff infection is to
stop the symptoms of diarrhea, abdominal upset and fever
• Once the diarrhea has resolved, the resident is safe to move about the facility
• Residents can carry C.diff in their bowels (colonized) for months after their diarrhea resolves
• After being treating a resident for CDI, there is NO VALUE in sending multiple C diff stool studies to see if “the infection has cleared”• Often you’ll continue to get positive
results which prompt unnecessary additional treatment
![Page 26: Managing MDROs in LTCFs National Center for Emerging and Zoonotic Infectious Diseases Division of Healthcare Quality Promotion Nimalie D. Stone, MD/MS](https://reader036.vdocuments.us/reader036/viewer/2022081518/551bcb84550346b4588b5143/html5/thumbnails/26.jpg)
Carbapenemase producing GNRs
• Carbapenemases are protein enzymes that break down all penicillins, cephalosporins and carbapenems
• There are different types of these enzymes some found in bugs like Acinetobacter and Pseudomonas ; others found in bugs like Klebsiella
• The genetic material also tends to carry resistance to other antibiotic classes like fluoroquinolones and aminoglycosides
• What’s really scary is that the resistance genes can be easily shared to other bacteria– Especially since we have lots of gram-negative bacteria
colonizing our bowels
Walsh, TR. Current Opin Infect Dis 2008;21:367-71
![Page 27: Managing MDROs in LTCFs National Center for Emerging and Zoonotic Infectious Diseases Division of Healthcare Quality Promotion Nimalie D. Stone, MD/MS](https://reader036.vdocuments.us/reader036/viewer/2022081518/551bcb84550346b4588b5143/html5/thumbnails/27.jpg)
States reporting Carbapenem-Resistant Enterobacteriaceae (CRE)
www.cdc.gov/HAI/organisms/cre.html
Monitor your culture reports for Carbapenem-resistant
GNRsq Widely reported in the US and specifically Georgia
q Ask your referral hospitals if they have had problems
q Being aware of new resistance patterns in your residents will help you prevent spread
![Page 28: Managing MDROs in LTCFs National Center for Emerging and Zoonotic Infectious Diseases Division of Healthcare Quality Promotion Nimalie D. Stone, MD/MS](https://reader036.vdocuments.us/reader036/viewer/2022081518/551bcb84550346b4588b5143/html5/thumbnails/28.jpg)
q Lab examined all the Acinetobacter cultured from people at 4 local hospitals over 5 years
q Classified as hospital-associated, NH-associated, or community-associated
q Wanted to see how antibiotic resistance emerged in this community
Case of an emerging MDRO….
![Page 29: Managing MDROs in LTCFs National Center for Emerging and Zoonotic Infectious Diseases Division of Healthcare Quality Promotion Nimalie D. Stone, MD/MS](https://reader036.vdocuments.us/reader036/viewer/2022081518/551bcb84550346b4588b5143/html5/thumbnails/29.jpg)
Multidrug-resistance emerged quickly
q Over 5 year period, antibiotic resistance increased dramatically q In the last 2 years of the study pan-resistant bacteria emerged
q Culture sources: Respiratory secretions (56%); Wounds (22%); Urine (12%)
Sengstock DM, et al. Clin Infect Dis. 2010 50(12): 1611-1616
![Page 30: Managing MDROs in LTCFs National Center for Emerging and Zoonotic Infectious Diseases Division of Healthcare Quality Promotion Nimalie D. Stone, MD/MS](https://reader036.vdocuments.us/reader036/viewer/2022081518/551bcb84550346b4588b5143/html5/thumbnails/30.jpg)
Healthcare facilities are the source of MDROs
Sengstock DM, et al. Clin Infect Dis. 2010 50(12): 1611-1616
q All the highly resistant bacteria were coming from patients in the hospital or those in the nursing homes – NOT from people living at home
![Page 31: Managing MDROs in LTCFs National Center for Emerging and Zoonotic Infectious Diseases Division of Healthcare Quality Promotion Nimalie D. Stone, MD/MS](https://reader036.vdocuments.us/reader036/viewer/2022081518/551bcb84550346b4588b5143/html5/thumbnails/31.jpg)
MDROs in the healthcare settingDEVELOPMENT
q Antibiotic pressureq Most common predictor of antibiotic resistance is
prior antibiotic use
q Device utilization q Biofilm formation on central lines, urinary catheters,
etc.
SPREADq Patient to patient transmission via healthcare
workersq Environmental / equipment contaminationq Role of colonization pressure on acquisition
![Page 32: Managing MDROs in LTCFs National Center for Emerging and Zoonotic Infectious Diseases Division of Healthcare Quality Promotion Nimalie D. Stone, MD/MS](https://reader036.vdocuments.us/reader036/viewer/2022081518/551bcb84550346b4588b5143/html5/thumbnails/32.jpg)
Resistance from antibiotic pressure
q At first most of the bacteria can be killed by the drug (green)
q But, once they are wiped out, the resistant bugs take over (red)
![Page 33: Managing MDROs in LTCFs National Center for Emerging and Zoonotic Infectious Diseases Division of Healthcare Quality Promotion Nimalie D. Stone, MD/MS](https://reader036.vdocuments.us/reader036/viewer/2022081518/551bcb84550346b4588b5143/html5/thumbnails/33.jpg)
Antibiotic use drives resistance
Johnson et al. Am J. Med. 2008; 121: 876-84
![Page 34: Managing MDROs in LTCFs National Center for Emerging and Zoonotic Infectious Diseases Division of Healthcare Quality Promotion Nimalie D. Stone, MD/MS](https://reader036.vdocuments.us/reader036/viewer/2022081518/551bcb84550346b4588b5143/html5/thumbnails/34.jpg)
Biofilm formation on device surfaces
q Biofilm: An collection of bacteria within a sticky film that forms a community on the surface of a device
http://www.ul.ie/elements/Issue7/Biofilm%20Information.htm
![Page 35: Managing MDROs in LTCFs National Center for Emerging and Zoonotic Infectious Diseases Division of Healthcare Quality Promotion Nimalie D. Stone, MD/MS](https://reader036.vdocuments.us/reader036/viewer/2022081518/551bcb84550346b4588b5143/html5/thumbnails/35.jpg)
Biofilm on an indwelling catheter
Tenke, P et al. World J. Urol. 2006; 24: 13-20
![Page 36: Managing MDROs in LTCFs National Center for Emerging and Zoonotic Infectious Diseases Division of Healthcare Quality Promotion Nimalie D. Stone, MD/MS](https://reader036.vdocuments.us/reader036/viewer/2022081518/551bcb84550346b4588b5143/html5/thumbnails/36.jpg)
Resistance develops within biofilms
q Bacteria within a biofilm are grow every differently from those floating around freelyq These changes in their growth make our antibiotics
less effectiveq Antibiotics can’t penetrate the biofilm to get to
the bacteria q This leads to much less drug available to treat the
bugsq Bacteria within the biofilm can talk to each
other and share the traits that allow some to be resistantq Over time more and more of them become resistant
as wellTenke, P et al. World J. Urol. 2006; 24: 13-20
![Page 37: Managing MDROs in LTCFs National Center for Emerging and Zoonotic Infectious Diseases Division of Healthcare Quality Promotion Nimalie D. Stone, MD/MS](https://reader036.vdocuments.us/reader036/viewer/2022081518/551bcb84550346b4588b5143/html5/thumbnails/37.jpg)
Improved Patient Outcomes Associated with Hand Hygiene
Ignaz Philipp Semmelweis
(1818-1865)
Chlorinated Lime Hand Antisepsis
Adapted from CDC. Prevent Antimicrobial Resistance: A Campaign for Clinicians. April 2002.
![Page 38: Managing MDROs in LTCFs National Center for Emerging and Zoonotic Infectious Diseases Division of Healthcare Quality Promotion Nimalie D. Stone, MD/MS](https://reader036.vdocuments.us/reader036/viewer/2022081518/551bcb84550346b4588b5143/html5/thumbnails/38.jpg)
![Page 39: Managing MDROs in LTCFs National Center for Emerging and Zoonotic Infectious Diseases Division of Healthcare Quality Promotion Nimalie D. Stone, MD/MS](https://reader036.vdocuments.us/reader036/viewer/2022081518/551bcb84550346b4588b5143/html5/thumbnails/39.jpg)
Bacterial contamination of HCW hands prior to hand hygiene in a LTCF
Mody L, et al. InfectContHospEpi. 2003; 24: 165-71
q Gram negative
bacteria were the most common bugs cultured from hands of staff
q Most Gram neg. bacteria live in the bowls or colonize the urine!!!
![Page 40: Managing MDROs in LTCFs National Center for Emerging and Zoonotic Infectious Diseases Division of Healthcare Quality Promotion Nimalie D. Stone, MD/MS](https://reader036.vdocuments.us/reader036/viewer/2022081518/551bcb84550346b4588b5143/html5/thumbnails/40.jpg)
Hand Hygiene
q Most effective and least costly means of preventing the transmission of MDROsqYet, compliance still ranges between ~30-60%
![Page 41: Managing MDROs in LTCFs National Center for Emerging and Zoonotic Infectious Diseases Division of Healthcare Quality Promotion Nimalie D. Stone, MD/MS](https://reader036.vdocuments.us/reader036/viewer/2022081518/551bcb84550346b4588b5143/html5/thumbnails/41.jpg)
Alcohol-based hand rub improves compliance and
decontamination
Mody L, et al. InfectContHospEpi. 2003; 24: 165-71
![Page 42: Managing MDROs in LTCFs National Center for Emerging and Zoonotic Infectious Diseases Division of Healthcare Quality Promotion Nimalie D. Stone, MD/MS](https://reader036.vdocuments.us/reader036/viewer/2022081518/551bcb84550346b4588b5143/html5/thumbnails/42.jpg)
Decreased MRSA infections associated with increased hand
hygiene compliance
Pittet, D et al.Lancet 2000;356:1307-12
![Page 43: Managing MDROs in LTCFs National Center for Emerging and Zoonotic Infectious Diseases Division of Healthcare Quality Promotion Nimalie D. Stone, MD/MS](https://reader036.vdocuments.us/reader036/viewer/2022081518/551bcb84550346b4588b5143/html5/thumbnails/43.jpg)
![Page 44: Managing MDROs in LTCFs National Center for Emerging and Zoonotic Infectious Diseases Division of Healthcare Quality Promotion Nimalie D. Stone, MD/MS](https://reader036.vdocuments.us/reader036/viewer/2022081518/551bcb84550346b4588b5143/html5/thumbnails/44.jpg)
The invisible reservoir of MDROs
• Image from Abstract: The Risk of Hand and Glove Contamination after Contact with a VRE (+) Patient Environment. Hayden M, ICAAC, 2001, Chicago, IL.
X marks the locations where VRE was isolated in this room
Slide courtesy of Teresa Fox, GA Div PH
![Page 45: Managing MDROs in LTCFs National Center for Emerging and Zoonotic Infectious Diseases Division of Healthcare Quality Promotion Nimalie D. Stone, MD/MS](https://reader036.vdocuments.us/reader036/viewer/2022081518/551bcb84550346b4588b5143/html5/thumbnails/45.jpg)
Duration of environmental contamination by MDROs
![Page 46: Managing MDROs in LTCFs National Center for Emerging and Zoonotic Infectious Diseases Division of Healthcare Quality Promotion Nimalie D. Stone, MD/MS](https://reader036.vdocuments.us/reader036/viewer/2022081518/551bcb84550346b4588b5143/html5/thumbnails/46.jpg)
Colonization pressure on risk of acquisition
q Colonization pressure: Presence of other MDRO carriers on a unit will increase the risk of MDRO acquisition to a non-carrier close by
q Studies have demonstrated the impact of colonization pressure on acquisition of MRSA, VRE and CDI
q Both asymptomatic carriers (colonized) and actively infected individuals can be a source for transmission (spread) on a unit
Williams VR et al. Am J Infect Control. 2009 Mar;37(2):106-10Bonten MJ et al. Arch Intern Med. 1998 May 25;158(10):1127-32.Dubberke ER et al. Arch Intern Med. 2007 May 28;167(10):1092-7
![Page 47: Managing MDROs in LTCFs National Center for Emerging and Zoonotic Infectious Diseases Division of Healthcare Quality Promotion Nimalie D. Stone, MD/MS](https://reader036.vdocuments.us/reader036/viewer/2022081518/551bcb84550346b4588b5143/html5/thumbnails/47.jpg)
Colonization pressure: C.diff example
Unit AFewer patients with active CDI
=lower risk of acquiring CDI
Unit BMore patients with active CDI=higher risk of acquiring CDI
CDI pressure=1 × days in unit
CDI pressure=5 × days in unit
Dubberke ER, et al. Clin Infect Dis. 2007;45:1543-1549.Dubberke ER et al. Arch InternMed.2007;167(10):1092-7
![Page 48: Managing MDROs in LTCFs National Center for Emerging and Zoonotic Infectious Diseases Division of Healthcare Quality Promotion Nimalie D. Stone, MD/MS](https://reader036.vdocuments.us/reader036/viewer/2022081518/551bcb84550346b4588b5143/html5/thumbnails/48.jpg)
Key MDRO Prevention Strategies
q Assessing hand hygiene practicesq Implementing Contact Precautionsq Recognizing previously colonized patientsq Rapidly reporting MDRO lab resultsq Strategically place residents based on MDRO
risk factors q Careful device utilizationq Antibiotic stewardshipq Inter-facility communication
![Page 49: Managing MDROs in LTCFs National Center for Emerging and Zoonotic Infectious Diseases Division of Healthcare Quality Promotion Nimalie D. Stone, MD/MS](https://reader036.vdocuments.us/reader036/viewer/2022081518/551bcb84550346b4588b5143/html5/thumbnails/49.jpg)
Assessing Hand Hygiene
• Hand hygiene should be a cornerstone of prevention efforts
• As part of a hand hygiene intervention, consider:– Ensuring easy access to soap and
water/alcohol-based hand gels– Observation of practices - particularly
around high-risk situations (before and after contact with colonized or infected patients)
– Feedback – “Just in time” feedback if failure to perform hand hygiene observed
![Page 50: Managing MDROs in LTCFs National Center for Emerging and Zoonotic Infectious Diseases Division of Healthcare Quality Promotion Nimalie D. Stone, MD/MS](https://reader036.vdocuments.us/reader036/viewer/2022081518/551bcb84550346b4588b5143/html5/thumbnails/50.jpg)
Implementing Contact Precautions
• Involves use of gown and gloves for patient care– Don equipment prior to room entry– Remove prior to room exit
• Selective roommate placement for MDRO colonized/infected individuals
• Observation of practices - particularly around high-risk situations
• Use of dedicated non-essential items may help decrease transmission due to contamination– Blood pressure cuffs; Stethoscopes; IV poles and pumps
![Page 51: Managing MDROs in LTCFs National Center for Emerging and Zoonotic Infectious Diseases Division of Healthcare Quality Promotion Nimalie D. Stone, MD/MS](https://reader036.vdocuments.us/reader036/viewer/2022081518/551bcb84550346b4588b5143/html5/thumbnails/51.jpg)
Recognizing Prior Colonization
q Individuals can be colonized with MDROs for monthsq Being able to identify previously colonized or
infected individuals allows for application of appropriate interventions in a timely fashion
q Being an MDRO carrier should not prevent a resident from being admitted to a LTCF,q Knowledge allows us to plan for them to have the safest
careq For every resident carrying an MDRO that we know about,
there are probably 3 others we don’t know
![Page 52: Managing MDROs in LTCFs National Center for Emerging and Zoonotic Infectious Diseases Division of Healthcare Quality Promotion Nimalie D. Stone, MD/MS](https://reader036.vdocuments.us/reader036/viewer/2022081518/551bcb84550346b4588b5143/html5/thumbnails/52.jpg)
Strategic placement of residents based on risk factors
• Base new roommate assignments on resident characteristics– Wounds, devices, current antibiotics,
incontinence are all risks for being an MDRO carrier or acquiring a new MDRO
– Try to avoid placing two high risk residents together
• Don’t necessarily change stable room assignments just because of a new culture result unless it now poses new risk– Roommates who’ve been together for a long
time have already had opportunity to share organisms in the past (even if you only learned about it recently)
![Page 53: Managing MDROs in LTCFs National Center for Emerging and Zoonotic Infectious Diseases Division of Healthcare Quality Promotion Nimalie D. Stone, MD/MS](https://reader036.vdocuments.us/reader036/viewer/2022081518/551bcb84550346b4588b5143/html5/thumbnails/53.jpg)
Prompt Recognition of MDROs in Laboratory Reports
• Facilities should have a mechanism for rapidly communicating positive MDRO lab results to clinical area– Allows for rapid initiation of interventions on
newly identified MDRO carriers
• Consider implementing precautions while waiting for results from the lab if an MDRO is possible– For example, contact precautions for a resident
with diarrhea while waiting for results of a C diff stool study
![Page 54: Managing MDROs in LTCFs National Center for Emerging and Zoonotic Infectious Diseases Division of Healthcare Quality Promotion Nimalie D. Stone, MD/MS](https://reader036.vdocuments.us/reader036/viewer/2022081518/551bcb84550346b4588b5143/html5/thumbnails/54.jpg)
Careful Device Utilization
• Know the population of residents with indwelling medical devices– May require focused infection surveillance
• Continually assess the ongoing need for devices– Develop a bladder protocol for urinary catheter removal– Resist the temptation to retain IV lines beyond the
duration of treatment “just in case”
• Ensure staff are comfortable and trained on handling/maintenance of medical devices
![Page 55: Managing MDROs in LTCFs National Center for Emerging and Zoonotic Infectious Diseases Division of Healthcare Quality Promotion Nimalie D. Stone, MD/MS](https://reader036.vdocuments.us/reader036/viewer/2022081518/551bcb84550346b4588b5143/html5/thumbnails/55.jpg)
Antibiotic Stewardship
• Careful antibiotic use is a critical component in the control of MDROs
• Know the frequency/indications for antibiotic use by medical providers in your facility– Apply criteria to assess utilization in a standard way
• Develop standard protocols for communicating concerns and assessing residents who are suspected to have an infection between nursing and medical staff– Ensure documentation of signs/symptoms is complete
![Page 56: Managing MDROs in LTCFs National Center for Emerging and Zoonotic Infectious Diseases Division of Healthcare Quality Promotion Nimalie D. Stone, MD/MS](https://reader036.vdocuments.us/reader036/viewer/2022081518/551bcb84550346b4588b5143/html5/thumbnails/56.jpg)
Case study on care transitionsq A LTC resident was transferred to a local
ED with worsening lower extremity swelling and shortness of breathq Resident’s history included coronary heart
disease, Diabetes with neuropathy, enlarged prostate
q Diagnosed with worsening heart failure admitted to ICU for cardiac monitoring and fluid management
q A urinary catheter was placed at the time of admission and a specimen was sent for UA/culture in ED. q Based on the UA, the patient was started on
antibiotics
![Page 57: Managing MDROs in LTCFs National Center for Emerging and Zoonotic Infectious Diseases Division of Healthcare Quality Promotion Nimalie D. Stone, MD/MS](https://reader036.vdocuments.us/reader036/viewer/2022081518/551bcb84550346b4588b5143/html5/thumbnails/57.jpg)
Case study (continued)
q After treatment for heart failure and the positive urine culture, the resident was discharged backed to the LTC facility with the catheter in place.
q Prior to removing the urinary catheter a repeat culture was sent which grew VREq A second course of antibiotics was initiated
q Two weeks later the resident developed diarrhea and fever q Stool sample was positive C. Diff toxin test.
![Page 58: Managing MDROs in LTCFs National Center for Emerging and Zoonotic Infectious Diseases Division of Healthcare Quality Promotion Nimalie D. Stone, MD/MS](https://reader036.vdocuments.us/reader036/viewer/2022081518/551bcb84550346b4588b5143/html5/thumbnails/58.jpg)
Issues raised by our case
q Is the practice of screening urine cultures on admission a valuable strategy?q What are the pros/cons
q Did the resident continue to need the urinary catheter once the CHF was managed?q How is resident functionality communicated at
time of transferq How are antibiotics used in both acute/LTC
facilities in this shared population?q Who is accountable for the complications of
antibiotic use?
![Page 59: Managing MDROs in LTCFs National Center for Emerging and Zoonotic Infectious Diseases Division of Healthcare Quality Promotion Nimalie D. Stone, MD/MS](https://reader036.vdocuments.us/reader036/viewer/2022081518/551bcb84550346b4588b5143/html5/thumbnails/59.jpg)
Inter-facility Communication
• Mechanism for communicating MDRO carriage and other risk factors at time of transfer between facilities
• Critical components:– MDRO history of current infection or carriage– Device utilization– Current antibiotic treatments (indication/duration)– Bedside care issues (wounds, continence, etc)
![Page 60: Managing MDROs in LTCFs National Center for Emerging and Zoonotic Infectious Diseases Division of Healthcare Quality Promotion Nimalie D. Stone, MD/MS](https://reader036.vdocuments.us/reader036/viewer/2022081518/551bcb84550346b4588b5143/html5/thumbnails/60.jpg)
![Page 61: Managing MDROs in LTCFs National Center for Emerging and Zoonotic Infectious Diseases Division of Healthcare Quality Promotion Nimalie D. Stone, MD/MS](https://reader036.vdocuments.us/reader036/viewer/2022081518/551bcb84550346b4588b5143/html5/thumbnails/61.jpg)
Summary of Prevention Strategies
q Assessing hand hygiene practicesq Implementing Contact Precautionsq Recognizing previously colonized patientsq Rapidly reporting MDRO lab resultsq Strategically place residents based on MDRO
risk factors q Careful device utilizationq Antibiotic stewardshipq Inter-facility communication
![Page 62: Managing MDROs in LTCFs National Center for Emerging and Zoonotic Infectious Diseases Division of Healthcare Quality Promotion Nimalie D. Stone, MD/MS](https://reader036.vdocuments.us/reader036/viewer/2022081518/551bcb84550346b4588b5143/html5/thumbnails/62.jpg)
q Describes the impact of regionally implemented infection control strategies to address VRE emerging in the Siouxland region of Iowa, Nebraska and S. Dakota
q Three annual point prevalence surveys (active surveillance) for VRE among patients/residents in participating acute/long-term care facilities
Story of Success…
![Page 63: Managing MDROs in LTCFs National Center for Emerging and Zoonotic Infectious Diseases Division of Healthcare Quality Promotion Nimalie D. Stone, MD/MS](https://reader036.vdocuments.us/reader036/viewer/2022081518/551bcb84550346b4588b5143/html5/thumbnails/63.jpg)
Ostrowsky BE et al. New Eng J Med 2001 344: 1427-1433
IC practice guidelines for facilities
![Page 64: Managing MDROs in LTCFs National Center for Emerging and Zoonotic Infectious Diseases Division of Healthcare Quality Promotion Nimalie D. Stone, MD/MS](https://reader036.vdocuments.us/reader036/viewer/2022081518/551bcb84550346b4588b5143/html5/thumbnails/64.jpg)
Ostrowsky BE et al. New Eng J Med 2001 344: 1427-1433
VRE prevalence decreased following prevention
interventionq 32 Facilities participated in 1997 and 1998 (4 acute/ 28 LTC) vs. 30 in1999 (4 acute/ 26 LTC)
q Overall 85%-89% of eligible patients/ residents cultured each year§ 52-59% in acute care§ 90-95% in LTC
![Page 65: Managing MDROs in LTCFs National Center for Emerging and Zoonotic Infectious Diseases Division of Healthcare Quality Promotion Nimalie D. Stone, MD/MS](https://reader036.vdocuments.us/reader036/viewer/2022081518/551bcb84550346b4588b5143/html5/thumbnails/65.jpg)
Critical message about collaboration
Ostrowsky BE et al. New Eng J Med 2001 344: 1427-1433
![Page 66: Managing MDROs in LTCFs National Center for Emerging and Zoonotic Infectious Diseases Division of Healthcare Quality Promotion Nimalie D. Stone, MD/MS](https://reader036.vdocuments.us/reader036/viewer/2022081518/551bcb84550346b4588b5143/html5/thumbnails/66.jpg)
Thank you!!
National Center for Emerging and Zoonotic Infectious Diseases
Division of Healthcare Quality Promotion
Email: [email protected] with questions/comments